Frankfurt - Delayed Quote EUR
Biovica International AB (publ) (9II.F)
0.0504
0.0000
(0.00%)
At close: May 19 at 8:11:52 AM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in SEK | Current Qtr. (Apr 2025) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | -- | 1 | 1 |
| Avg. Estimate | 5M | -- | 11M | 94M |
| Low Estimate | 5M | -- | 11M | 94M |
| High Estimate | 5M | -- | 11M | 94M |
| Year Ago Sales | 1.9M | -- | 7.29M | 11M |
| Sales Growth (year/est) | 163.30% | -- | 50.89% | 754.55% |
EPS Trend
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 9II.F | -- | -- | -- | -- |
| S&P 500 | 13.32% | 2.67% | 7.78% | 13.75% |
Related Tickers
PHGN.BE Pharming Group
0.8505
+2.72%
ACTI.ST Active Biotech AB (publ)
0.1172
-6.09%
ONCO.ST Oncopeptides AB (publ)
1.9980
-0.10%
XBRANE.ST Xbrane Biopharma AB (publ)
0.2680
+5.10%
PHAR Pharming Group N.V.
9.31
-5.67%
ZEAL.CO Zealand Pharma A/S
416.00
-0.26%
RCKT Rocket Pharmaceuticals, Inc.
6.45
-0.77%
PLX Protalix BioTherapeutics, Inc.
1.6800
+0.60%
IVVD Invivyd, Inc.
0.7756
-0.14%
IBRX ImmunityBio, Inc.
2.8000
-1.41%